Speaker: Jonathan Ledermann, UK
In this ESMO How To video, Jonathan Ledermann advises how to discuss primary surgery vs neoadjuvant chemotherapy with patients with Ovarian Cancer. He explains how to select first-line treatment regimen, and identify patients who may benefit from molecularly targeted therapies.
Produced by the European Society for Medical Oncology
oncologpro.esmo.org